Bigul

Board recommends Dividend

Zydus Wellness Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2015, inter alia, has recommended a declaration of dividend @ 60% i.e. Rs. 6/- per Equity Share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2015.
14-05-2015
Bigul

Financial Results & Auditors Report for March 31, 2015 (Audited)

Zydus Wellness Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2015.
14-05-2015
Bigul

Board to consider Dividend

Zydus Wellness Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 14, 2015, inter alia, to approve the audited financial results for the quarter / year ended March 31, 2015 and to recommend dividend on equity shares of the Company for the year ended on March 31, 2015.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading)...
27-04-2015
Bigul

Zydus ties up with US-based R&D to develop vaccine

Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine aga...
24-04-2015
Bigul

Resignation of Managing Director

Zydus Wellness Ltd has informed BSE that Mr. Elkana N. Ezekiel has tendered his resignation as a Director / Managing Director of the Company as well as from the Committees of the Board in which he is a member, with effect from April 14, 2015.
14-04-2015
Bigul

Shareholding Pattern For March 31, 2015

Zydus Wellness Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.
07-04-2015
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Zydus Wellness Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
19-03-2015
Bigul

Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Ganesh N Nayak has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
18-03-2015
Bigul

Financial Results & Limited Review for Dec 31, 2014

Zydus Wellness Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.
09-02-2015
Next Page
Close

Let's Open Free Demat Account